Michael D. Chuong M.D.,
is a radiation/hematologist oncologist at Miami Cancer Institute. Board-certified in radiation oncology, Dr. Chuong completed his residency in radiation oncology at the University of South Florida/H. Lee Moffitt Cancer Center and Research Institute, where he previously served as chief resident. His clinical specialty and research focus is on the use of radiation therapy to treat gastrointestinal cancers and lymphomas.
Minesh P. Mehta, M.D.,
is deputy director and chief of radiation oncology at Miami Cancer Institute. Board-certified in radiation oncology, he graduated with the highest honors from the University of Zambia School of Medicine and completed a residency at the University of Wisconsin, where he was chief resident in radiation oncology. As chairman of the medical school’s Department of Human Oncology, he led research studies, technology development and expansion at the cancer center. He also headed its brain tumor program for more than 15 years, leading to his national leadership role in clinical trials research within national co-operative groups such as NRG Oncology, Radiation Therapy Oncology Group, North American Brain Tumor Consortium, Eastern Cooperative Oncology Group and Children’s Cooperative Group.
Yazmin Odia, M.D., M.S.,
is a neuro-oncologist at Miami Cancer Institute. She graduated from the University of Chicago's Pritzker School of Medicine, completed her internship and residency at the Johns Hopkins University School of Medicine and completed a fellowship at the National Cancer Institute. Dr. Odia is Board-certified in neurology, and is also certified in neuro-oncology by the United Council for Neurologic Subspecialties. She is renowned for her important research work in the field of neuro-oncology, including looking at the clinical correlates of novel biomarkers in various brain tumors, and has had many medical papers published.
Kevin Abrams, M.D.,
is medical director of neuroradiology and magnetic resonance imaging at Baptist, Homestead and South Miami Hospitals and medical director of imaging at Baptist Hospital of Miami. He graduated from the State University of New York at Stony Brook and received his M.D. degree from the State University of New York Health Science Center at Syracuse. He completed an internship in internal medicine at the University of Connecticut; a diagnostic radiology residency at the Hospital of St. Raphael, a Yale affiliate; and a fellowship in neuroradiology at the University of Miami/Jackson Memorial Hospital.
Kenneth Aldape, M.D.,
a neuropathologist, is a professor of pathology at the University of Toronto. His research interest is in primary brain tumors. Dr. Aldape’s work characterizes glioma subtypes as well as identifies clinically relevant molecular alterations in these tumors.
Luis Borba, M.D., Ph.D.,
is professor and chairman of neurosurgery at the Federal University of Parana, Brazil. He received his medical degree from the Federal University of Pelotas and completed his residency in neurosurgery at the Federal University of Parana and his fellowship in skull base surgery at the University of Arkansas for Medical Sciences. Dr. Borba is president-elect of the World Congress of Skull Base Societies and president-elect of the Brazilian Neurosurgery Society. He is on the editorial board of the Brazilian Journal of Neurosurgery and of the Neurological Review in Zurich. His special interests include meningiomas, schwannomas, pituitary adenomas, gloms jugulare tumors, craniocervical junction lesions.
Jeremy Chambers, Ph.D.,
is an assistant professor of cellular biology and pharmacology at Florida International University’s Herbert Wertheim College of Medicine. Dr. Chambers received his Ph.D. in biochemistry from Clemson University and a postdoctoral degree from the University of Pennsylvania School of Medicine. His focus is on understanding how communication among mitochondria and between mitochondria and other organelles influences aging and age-related diseases.
Marcio Fagundes, M.D.,
is a radiation oncologist at Miami Cancer Institute. He attended medical school at Universidad Federal Do Rio Grande Do Sul in Brazil. He completed his internship at Jackson Memorial Hospital, his residency in radiation oncology at Sylvester Comprehensive Cancer Center and a fellowship in radiation oncology at Massachusetts General Hospital, Harvard. Dr. Fagundes has conducted significant research in the field of proton therapy.
Mark R. Gilbert, M.D.,
is senior investigator and chief of the neuro-oncology branch at the National Cancer Institute and National Institute of Neurological Disorders and Stroke in Bethesda, Maryland. Dr. Gilbert's research interests center on developing new treatment strategies for patients with malignant primary brain tumors.
Vinai Gondi, M.D.,
is a Board certified radiation oncologist at Northwestern Medicine Chicago Proton Center and Northwestern Medicine Central DuPage Cancer Center. He is a clinical assistant professor at the University of Wisconsin Comprehensive Cancer Center, where he remains engaged in research and teaching activities. Dr. Gondi is a graduate of the University of Wisconsin-Madison and attended medical school at Columbia University College of Physicians & Surgeons. He completed his residency training in radiation oncology at the University of Wisconsin Comprehensive Cancer Center, where he trained under leaders in the field of radiation oncology and earned a Capstone Certificate in Clinical Research.
Geraldo Guinto, M.D.,
is professor and chief of neurosurgery at the Hospital de Especialidades Centro Médico Nacional Siglo XX in Mexico City. He is professor and chief of neurology at Universidad La Salle School of Medicine – professor and chief of neurology at Universidad Anáhuac School of Medicine and member of Academia Nacional de Medicina de Mexico and Academia Mexicana de Cirugía, Sistema Nacional de Investigadores. Dr. Quinto attended medical school at Universidad La Salle in Mexico City and completed neurosurgical training at Hospital de Especialidades Centro Médico Nacional Siglo XXI and a fellowship in skull base surgery at Presbyterian University Hospital in Pittsburgh.
Matthew Hall, M.D.,
is lead pediatric radiation oncologist at Miami Cancer Institute. After earning his medical degree at the University of Illinois College of Medicine, he completed his internship at Saint Francis Medical Center’s residency program at City of Hope National Medical Center and a fellowship at the University of Florida’s Proton Therapy Institute.
Andrei Holodny, M.D.,
is chief of neuroradiology services at Memorial Sloan Kettering Cancer Center. He attended medical school at the University of Medicine and Dentistry of New Jersey. He completed his residencies at the New York Hospital-Cornell Medical Center and New York University, and fellowships at New York University and National Hospital in Oslo. Dr. Holodny is a Board-certified clinical and research neuroradiologist with a special interest in the use of advanced magnetic resonance imaging of brain tumors.
Fabio Iwamoto, M.D.,
is deputy director of neuro-oncology at Columbia University. He completed his residency at New York-Presbyterian/Weill Cornell Medical Center and a neuro-oncology fellowship at Memorial Sloan Kettering Cancer Center. For over three years, Dr. Iwamoto was an attending physician and an investigator at the Neuro-oncology Branch, a trans-institute branch of the National Cancer Institute and National Institute of Neurological Disorders and Stroke. At the intramural NIH, Dr. Iwamoto was a principal investigator in early-phase clinical trials for brain tumors, and worked with laboratory and computational scientists on several translational projects in brain tumors. He is an expert in the diagnosis, management and treatment of brain and spinal cord tumors, as well as neurological complications of cancer.
Sakhrat Khizroev, Ph.D.,
is a professor of electrical engineering and professor of cellular biology at Florida International University’s Herbert Wertheim College of Medicine. Dr. Khizroev received his Ph.D. in electrical and computer engineering from Carnegie Mellon University. He spent four years as a research staff member with Seagate research and one year as a doctoral intern with IBM Almaden Research Center. His research focus is on the basic study of nanomagnetic and spintronic devices to enable leapfrog advances in a broad range of applications, including next-generation information processing and nanomedicine.
Rupesh Kotecha, M.D.,
is a staff physician in the department of radiation oncology at Miami Cancer Institute. He received his bachelor’s degree in physiology and his medical degree from Michigan State University College of Human Medicine through the accelerated M.D. Medical Scholars Program. He completed his internship and radiation oncology residency at Cleveland Clinic. Dr. Kotecha’s clinic interests and research experience have primarily focused on the treatment of patients with stereotactic radiosurgery and stereotactic body radiation therapy. He has co-written numerous radiation oncology chapters and published multiple manuscripts on the treatment of patients with CNS malignancies and benign diseases. His current research investigates the use of targeted immunotherapies with stereotactic radiosurgery and the molecular profiles associated with radiation response in patients with brain metastases.
Guy M. McKhann II, M.D.,
is a Florence Irving associate professor of neurological surgery, director of epilepsy and movement disorder surgery, adult hydrocephalus center and awake brain mapping for tumors and epilepsy at Columbia University Medical Center New York Presbyterian Hospital. Dr. McKhann attended Yale University School of Medicine and completed his residency and internship at the University of Washington. His areas of technical expertise include awake brain mapping; minimally invasive, computer-guided microneurosurgery; stereotactic laser ablation for tumors and epilepsy; Gamma Knife radiosurgery; deep brain stimulation; neuroendoscopy; and cerebrospinal fluid shunting.
David Reardon, M.D.,
is clinical director of neuro-oncology at Dana-Farber Cancer Institute and a clinical professor of medicine at Harvard Medical School. Dr. Reardon attended Tufts Medical School and completed his residency at Johns Hopkins Hospital in pediatrics and his fellowship at the University of Michigan Hospital, MOTT Children’s Hospital, in pediatric hematology/oncology. His interests are brain and spinal tumors, clinical trials in neuro-oncology, targeted therapies, anti-angiogenic treatments, immunotherapy and convection-enhanced delivery.
Vitaly Siomin, M.D.,
is a neurosurgeon and medical director of the brain tumor program at Baptist Health Neuroscience Center. He received his medical degree from I.M. Setchenov’s Moscow Medical Academy, with a semester at Columbia University’s College of Physicians and Surgeons. Board-certified in neurological surgery, Dr. Siomin completed fellowships in pediatric neurosurgery at Tel Aviv Sourasky Medical Center; neurosurgery/neuro-oncology at Toronto Western Hospital; and brain tumors at Cleveland Clinic Foundation, where he also did his neurosurgery residency. He has participated in courses of the European Association of Neurological Surgeons (spinal, vascular, tumors) and Cleveland Clinic (Gamma Knife), and has authored or co-authored numerous publications.
Roger Stupp, M.D.,
is chief of neuro-oncology and professor of neurological surgery in neurology and oncology at Northwestern University Feinberg School of Medicine and Robert H. Lurie Comprehensive Cancer Center of Northwestern University. He earned his medical degree from the University of Zurich and completed an internship and residency in internal medicine at the Langenthal/Bern County Hospital and University Hospital Zurich. He then moved to the United States for a three-year fellowship in hematology/oncology at the University of Chicago. Dr. Stupp is a leading authority on the treatment of primary and metastatic brain cancer. His ongoing research touches not only primary and secondary brain tumors, but also head and neck tumors and lung cancers.
Javier Torres-Roca, M.D.,
is chief of research and an associate member of the department of radiation oncology at Moffitt Cancer Center in Tampa, as well as associate professor of oncologic sciences at the University of South Florida’s Morsani College of Medicine. A graduate of the University of Puerto Rico Medical School, he completed research fellowships in immunology and genetics at the Institut Pasteur in Paris and Stanford University in California. He subsequently trained in radiation oncology at the University of California, Irvine. Dr. Torres-Roca’s research interests include the development of genomic strategies to personalize radiation therapy for individual patients. His clinical interests are in genitourinary and cutaneous malignancies. He is proficient in all the latest radiation technologies, including IMRT, IGRT, VMAT and SBRT.
Michael Vogelbaum, M.D., Ph.D., FACS,
has joint appointments with the Cleveland Clinic Gamma Knife Center and the Lerner Research Institute’s Department of Cancer Biology. He is associate director of the Brain Tumor and Neuro-Oncology Center and director of the Center for Translational Therapeutics at Cleveland Clinic. A graduate of the University of Virginia School of Medicine, he received his specialty training in neurosurgery at the Barnes-Jewish Hospital. He is Board-certified in neurological surgery. Specializing in the diagnosis and treatment of benign and malignant tumors of the brain and spinal cord, Dr. Vogelbaum also is interested in stereotactic (image-guided) surgery, Gamma Knife therapy and the molecular biology of brain tumors.
Peter Volsky, M.D.,
is an otolaryngologist with Baptist Health Quality Network, an affiliate of Baptist Health South Florida.
Eduardo Weltman, M.D.,
is a professor of radiation oncology at University of São Paulo Medical School, and is the current president of the Brazilian Radiation Oncology Society (SBRT). Dr. Weltman completed his medical degree and residency in radiology oncology at Faculdade de Medicina da Universidade de São Paulo. His expertise is in general and pediatric radiation oncology, neuroradiology, radiosurgery and conformal radiotherapy.
Disclosure Policy and Disclaimer